Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet- induced obese rats

[1]  N. Allouche,et al.  Inhibitory Activities of Zygophyllum album: A Natural Weight-Lowering Plant on Key Enzymes in High-Fat Diet-Fed Rats , 2012, Evidence-based complementary and alternative medicine : eCAM.

[2]  R. Kasetti,et al.  Cinnamic acid as one of the antidiabetic active principle(s) from the seeds of Syzygium alternifolium. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  P. Barie,et al.  Cefepime Dosing in the Morbidly Obese Patient Population , 2012, Obesity Surgery.

[4]  Jie Li,et al.  Slower gastric emptying in high-fat diet induced obese rats is associated with attenuated plasma ghrelin and elevated plasma leptin and cholecystokinin concentrations , 2011, Regulatory Peptides.

[5]  S. Subramaniam,et al.  Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits , 2011, Evidence-based complementary and alternative medicine : eCAM.

[6]  Prateek Sharma.  Cinnamic acid derivatives : A new chapter of various pharmacological activities , 2011 .

[7]  D. Stewart,et al.  Berry polyphenols inhibit pancreatic lipase activity in vitro. , 2009 .

[8]  W. Hofmann,et al.  Angiotensin-Converting Enzyme (ACE) Inhibitors Modulate Cellular Retinol-Binding Protein 1 and Adiponectin Expression in Adipocytes via the ACE-Dependent Signaling Cascade , 2009, Molecular Pharmacology.

[9]  R. Chakrabarti.  Pharmacotherapy of obesity: emerging drugs and targets , 2009, Expert opinion on therapeutic targets.

[10]  S. Adisakwattana,et al.  Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. , 2008, Journal of agricultural and food chemistry.

[11]  K. Bhutani,et al.  Pancreatic lipase inhibitors from natural sources: unexplored potential. , 2007, Drug discovery today.

[12]  Hyounjeong Choi,et al.  A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model. , 2007, Biochemical and biophysical research communications.

[13]  L. Peruzzi,et al.  In vitro angiotensin converting enzyme inhibiting activity of Salsola oppositifolia Desf., Salsola soda L. and Salsola tragus L. , 2007, Natural product research.

[14]  W. Xie,et al.  Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice , 2007, International Journal of Obesity.

[15]  C. Mantzoros,et al.  Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[16]  T. Iwashita,et al.  Inhibitory Effects of Oolong Tea Polyphenols on Pancreatic Lipase in Vitro , 2005 .

[17]  Zinka Pavletić,et al.  Salsola soda L. , 2004 .

[18]  M. Hanefeld,et al.  The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo‐controlled trial , 2002, Diabetes, obesity & metabolism.

[19]  G. Bray,et al.  Drug treatment of obesity. , 2001, Reviews in endocrine & metabolic disorders.

[20]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[21]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[22]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[23]  P. Amouyel,et al.  The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. , 1997, Journal of the American College of Cardiology.

[24]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[25]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[26]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[27]  R. Skidgel,et al.  The angiotensin I-converting enzyme. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[28]  Skidgel Ra,et al.  The angiotensin I-converting enzyme. , 1977 .

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[30]  Z. Asperger.  [Obesity as a problem in medical practice]. , 1952, Medicinski glasnik.